[Acute hepatitis C: a retrospective study of 62 cases]

Gastroenterol Clin Biol. 2002 Nov;26(11):994-1000.
[Article in French]

Abstract

Objectives: Retrospective study of acute hepatitis C cases observed in general hospitals.

Methods: Questionnaire sent by mail to members of the Association Nationale des Gastroentérologues des Hôpitaux Généraux (ANGH) in December, 1997. Data were updated in September, 2001.

Results: Sixty-two cases were reported in 40 centers. Patients were predominantly female (58%), the median age was 33 years-old. Symptoms revealed the disease in 65% of cases (jaundice in 53%) and screening in 30%. The main suspected routes of infection were intravenous drug use (32%), nosocomial exposure (29%) and professional accidents (11%). Sustained viral clearance occurred in 12 out of the 28 patients who were followed without treatment for 6 months, in 14 of 30 treated early, and 4 out of 7 treated secondarily with interferon alpha alone. No prognostic factor was identified, except for a low total dose of interferon in treated patients.

Conclusions: Acute hepatitis C is a rare disease, occurring in younger and more often in female patients than chronic hepatitis C. Spontaneous cure is not infrequent, and could justify a period of simple follow-up before starting treatment. A national observatory would help for epidemiologic surveillance and therapeutic studies.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antiviral Agents / therapeutic use
  • Cross Infection / etiology
  • Data Interpretation, Statistical
  • Female
  • Follow-Up Studies
  • Hepatitis C / diagnosis
  • Hepatitis C / drug therapy
  • Hepatitis C / epidemiology*
  • Hepatitis C / etiology
  • Humans
  • Interferon-alpha / therapeutic use
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Substance Abuse, Intravenous / complications
  • Surveys and Questionnaires
  • Time Factors

Substances

  • Antiviral Agents
  • Interferon-alpha